These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36542202)

  • 1. A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson's disease.
    Loureiro D; Bilbao R; Bordet S; Grasso L; Otero-Losada M; Capani F; Ponzo OJ; Perez-Lloret S
    Neurol Sci; 2023 Apr; 44(4):1211-1222. PubMed ID: 36542202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent effect of neurogenic orthostatic hypotension on mild cognitive impairment in Parkinson's disease.
    Kang SH; Chung SJ; Lee J; Koh SB
    Clin Auton Res; 2022 Feb; 32(1):43-50. PubMed ID: 34841452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthostatic Hypotension and Risk of Mild Cognitive Impairment and Dementia in Parkinson's Disease.
    Hiorth YH; Schulz J; Pedersen KF; Tysnes OB; Alves G
    Mov Disord Clin Pract; 2024 Nov; 11(11):1365-1372. PubMed ID: 39108067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment.
    Bocti C; Pépin F; Tétreault M; Cossette P; Langlois F; Imbeault H; Duval N; Lacombe G; Fulop T
    J Neurol Sci; 2017 Nov; 382():79-83. PubMed ID: 29111025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.
    Liebermann-Jordanidis H; Roheger M; Boosfeld L; Franklin J; Kalbe E
    J Parkinsons Dis; 2022; 12(6):1749-1782. PubMed ID: 35599499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthostatic intolerance predicts mild cognitive impairment: incidence of mild cognitive impairment and dementia from the Swedish general population cohort Good Aging in Skåne.
    Elmståhl S; Widerström E
    Clin Interv Aging; 2014; 9():1993-2002. PubMed ID: 25429211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthostatic Hypotension: An Important Risk Factor for Clinical Progression to Mild Cognitive Impairment or Dementia. The Amsterdam Dementia Cohort.
    Kleipool EEF; Trappenburg MC; Rhodius-Meester HFM; Lemstra AW; van der Flier WM; Peters MJL; Muller M
    J Alzheimers Dis; 2019; 71(1):317-325. PubMed ID: 31381517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?
    McDonald C; Newton JL; Burn DJ
    Mov Disord; 2016 Jul; 31(7):937-46. PubMed ID: 27091624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease.
    Kim JS; Oh YS; Lee KS; Kim YI; Yang DW; Goldstein DS
    Neurology; 2012 Sep; 79(13):1323-31. PubMed ID: 22972639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
    Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
    J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cognitive performance is associated with sleep efficiency measured by polysomnography in patients with Parkinson's disease.
    Sobreira EST; Sobreira-Neto MA; Pena-Pereira MA; Chagas MHN; Fernandes RMF; Eckeli AL; Tumas V
    Psychiatry Clin Neurosci; 2019 May; 73(5):248-253. PubMed ID: 30636105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
    Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
    Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.